These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIV. Crowe S; Cooper DA; Chambers DE Med J Aust; 1996 Mar; 164(5):290-5. PubMed ID: 8628165 [TBL] [Abstract][Full Text] [Related]
4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
5. Current HIV clinical trial design issues. Lange JM J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S47-51. PubMed ID: 8595508 [TBL] [Abstract][Full Text] [Related]
6. [Antiretroviral therapy. Current status and perspectives]. Lüthy R Internist (Berl); 1994 Oct; 35(10):896-900. PubMed ID: 8002223 [No Abstract] [Full Text] [Related]
7. Is there a role for non-nucleoside reverse transcriptase inhibitors in the treatment of HIV infection? Kilby JM; Saag MS Infect Agents Dis; 1994 Dec; 3(6):313-23. PubMed ID: 7534192 [TBL] [Abstract][Full Text] [Related]
8. HIV therapy advances. Early antiretroviral therapy. Cooper DA AIDS; 1994 Sep; 8 Suppl 3():S9-14. PubMed ID: 7840916 [TBL] [Abstract][Full Text] [Related]
9. Viral resistance and the selection of antiretroviral combinations. Larder BA J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S28-33. PubMed ID: 8595505 [TBL] [Abstract][Full Text] [Related]
10. [Causal therapy possibilities in HIV infections]. Baumgarten R Dermatol Monatsschr; 1989; 175(8):469-73. PubMed ID: 2676627 [TBL] [Abstract][Full Text] [Related]
11. HIV pathogenesis and treatment strategies. Vella S J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S20-3. PubMed ID: 8595503 [TBL] [Abstract][Full Text] [Related]
12. [Which is the strategy? The latest in the use of antiretrovirals]. Agosto M Sidahora; 1995; ():33-4. PubMed ID: 11363205 [TBL] [Abstract][Full Text] [Related]
13. Antiretroviral drug treatment for HIV/AIDS. Goldschmidt RH; Moy A Am Fam Physician; 1996 Aug; 54(2):574-80, 587-8. PubMed ID: 8701838 [TBL] [Abstract][Full Text] [Related]
14. Anti-HIV therapy lowers risk of AIDS, death in patients with intermediate-stage HIV disease. AIDS Patient Care; 1995 Dec; 9(6):303. PubMed ID: 11361440 [No Abstract] [Full Text] [Related]
15. Studies of zidovudine in combination with didanosine and zalcitabine. Jablonowski H J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509 [TBL] [Abstract][Full Text] [Related]
16. Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1. Commun Dis Rep CDR Wkly; 1995 Oct; 5(42):209. PubMed ID: 7496435 [No Abstract] [Full Text] [Related]
17. 3TC/AZT: just another combination. GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997 [TBL] [Abstract][Full Text] [Related]
18. [Treatment by antiviral drugs of HIV-infected patients]. Mayaud C Rev Pneumol Clin; 1993; 49(2):71-4. PubMed ID: 8272744 [No Abstract] [Full Text] [Related]